288 related articles for article (PubMed ID: 34034474)
1. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
2. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.
Yang Y; Xin Y; Ye F; Liu N; Zhang X; Wang Y; Li X; Fan Q; Zhou X; Chen Y
Int J Hyperthermia; 2021; 38(1):437-446. PubMed ID: 33724137
[TBL] [Abstract][Full Text] [Related]
3. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
[TBL] [Abstract][Full Text] [Related]
4. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
5. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
6. Prediction Model and Nomogram of Early Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation Based on Logistic Regression Analysis.
Ni Z; Wu B; Li M; Han X; Hao X; Zhang Y; Cheng W; Guo C
Ultrasound Med Biol; 2022 Sep; 48(9):1733-1744. PubMed ID: 35690523
[TBL] [Abstract][Full Text] [Related]
7. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation.
Chen Y; Yang Y; Zhang XY; Fan QS; Li X; Xin YJ; Cao XJ; Wang YN; Zhou X
Cardiovasc Intervent Radiol; 2021 Oct; 44(10):1551-1560. PubMed ID: 34036405
[TBL] [Abstract][Full Text] [Related]
8. Prognostic nomogram for hepatocellular carcinoma with radiofrequency ablation: a retrospective cohort study.
Lu Z; Sun Z; Liu C; Shi X; Li R; Shao W; Zheng Y; Li Y; Song J
BMC Cancer; 2021 Jun; 21(1):751. PubMed ID: 34187430
[TBL] [Abstract][Full Text] [Related]
9. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
[TBL] [Abstract][Full Text] [Related]
10. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
11. Construction of a novel radiomics nomogram for the prediction of aggressive intrasegmental recurrence of HCC after radiofrequency ablation.
Lv X; Chen M; Kong C; Shu G; Meng M; Ye W; Cheng S; Zheng L; Fang S; Chen C; Wu F; Weng Q; Tu J; Zhao Z; Ji J
Eur J Radiol; 2021 Nov; 144():109955. PubMed ID: 34600237
[TBL] [Abstract][Full Text] [Related]
12. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
[TBL] [Abstract][Full Text] [Related]
13. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
Liu W; Zhang F; Quan B; Li M; Lu S; Li J; Chen R; Yin X
Dis Markers; 2021; 2021():3514827. PubMed ID: 34840628
[TBL] [Abstract][Full Text] [Related]
15. Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Takuma Y; Shota I; Miyatake H; Uematsu S; Okamoto R; Araki Y; Takabatake H; Morimoto Y; Yamamoto H
Intern Med; 2018 Feb; 57(4):457-468. PubMed ID: 29151504
[TBL] [Abstract][Full Text] [Related]
16. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound.
Zhang W; Luo E; Gan J; Song X; Bao Z; Zhang H; Chen M
World J Surg Oncol; 2017 Jul; 15(1):122. PubMed ID: 28679433
[TBL] [Abstract][Full Text] [Related]
18. A Systemic Inflammation Response Index (SIRI)-Based Nomogram for Predicting the Recurrence of Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Xin Y; Zhang X; Li Y; Yang Y; Chen Y; Wang Y; Zhou X; Li X
Cardiovasc Intervent Radiol; 2022 Jan; 45(1):43-53. PubMed ID: 34561739
[TBL] [Abstract][Full Text] [Related]
19. Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study.
Yang Y; Chen Y; Zhang X; Xin Y; Wang Y; Li X; Fan Q; Zhou X; Ye F
Eur J Radiol; 2021 May; 138():109623. PubMed ID: 33711573
[TBL] [Abstract][Full Text] [Related]
20. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]